Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis

BACKGROUND: Scleroderma is a connective tissue disease causing fibrosis and commonly affects the skin and internal organs such as the GI tract, lungs, kidney and heart. Most people with scleroderma also have Raynaud's phenomenon (RP). One of the possible treatment options for RP in scleroderma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Pope, Janet, Fenlon, D, Thompson, A, Shea, Beverley, Furst, Dan, Wells, George A, Silman, Alan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 1998
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7032891/
https://ncbi.nlm.nih.gov/pubmed/10796396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000954
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller